The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8617-8629

  Liu, Guihua ^a   Wang, Xisheng ^a,b   Sun, Xiangzhou ^c   Deng, Chunhua ^c   Atala, Anthony ^a   Zhang, Yuanyuan ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cell therapy; Stress urinary incontinence (SUI); Urine derived stem cells (USCs); Vascular endothelial growth factor (VEGF)

Indexed keywords

CELL THERAPY; ENDOTHELIAL MARKER; GREEN FLUORESCENT PROTEIN; SKELETAL MYOBLASTS; STRESS URINARY INCONTINENCES; URINE-DERIVED STEM CELLS (USCS); VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BODY FLUIDS; CELL ENGINEERING; COLLAGEN; CYTOLOGY; MAMMALS; STEM CELLS; UROLOGY;

ENDOTHELIAL CELLS;

CD31 ANTIGEN; COLLAGEN; DESMIN; MYOD PROTEIN; MYOGENIC FACTOR 5; PROTEIN S 100; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HYDROGEL; INNERVATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; URINE DERIVED STEM CELL;

ADENOVIRIDAE; MUS MUSCULUS;

CELL THERAPY; STRESS URINARY INCONTINENCE (SUI); URINE-DERIVED STEM CELLS (USCS); VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ADENOVIRIDAE; ADULT; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; COLLAGEN TYPE I; DESMIN; ENDOTHELIAL CELLS; GENETIC VECTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGELS; MALE; MICE; MICE, NUDE; MUSCLE DEVELOPMENT; MUSCLES; MYOBLASTS, SKELETAL; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; URINARY INCONTINENCE, STRESS; URINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84882890381     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.077     Document Type: Article

References (36)

1. Dissaranan C., Cruz M.A., Couri B.M., Goldman H.B., Damaser M.S. Stem cell therapy for incontinence: where are we now? what is the realistic potential?. Curr Urol Rep 2011, 12:336-344.
2. Bent A.E., Tutrone R.T., McLennan M.T., Lloyd L.K., Kennelly M.J., Badlani G. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 2001, 20:157-165.
3. Yokoyama T., Pruchnic R., Lee J.Y., Chuang Y.C., Jumon H., Yoshimura N., et al. Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001, 7:395-404.
4. Gunetti M., Tomasi S., Giammo A., Boido M., Rustichelli D., Mareschi K., et al. Myogenic potential of whole bone marrow mesenchymal stem cells invitro and invivo for usage in urinary incontinence. PLoS One 2012, 7:e45538.
5. Lin G., Wang G., Banie L., Ning H., Shindel A.W., Fandel T.M., et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010, 12:88-95.
6. Lang R., Liu G., Shi Y., Bharadwaj S., Leng X., Zhou X., et al. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One 2013, 8:e53980.
7. Zhang Y., McNeill E., Tian H., Soker S., Andersson K.E., Yoo J.J., et al. Urine derived cells are a potential source for urological tissue reconstruction. JUrol 2008, 180:2226-2233.
8. Bodin A., Bharadwaj S., Wu S., Gatenholm P., Atala A., Zhang Y. Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials 2010, 31:8889-8901.
9. Liu G., Pareta R.A., Wu R., Shi Y., Zhou X., Liu H., et al. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials 2013, 34:1311-1326.
10. Bharadwaj S., Liu G., Shi Y., Markert C., Andersson K.E., Atala A., et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A 2011, 17:2123-2132.
11. Wu S., Liu Y., Bharadwaj S., Atala A., Zhang Y. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials 2011, 32:1317-1326.
12. Wu S., Wang Z., Bharadwaj S., Hodges S.J., Atala A., Zhang Y. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. JUrol 2011, 186:640-647.
13. Smaldone M.C., Chen M.L., Chancellor M.B. Stem cell therapy for urethral sphincter regeneration. Minerva Urol Nefrol 2009, 61:27-40.
14. Bharadwaj S., Liu G., Shi Y., Wu R., Yang B., He T., et al. Multi-potential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells 2013, [Epub ahead of print]. 10.1002/stem. 1424.
15. Djouad F., Bouffi C., Ghannam S., Noel D., Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 2009, 5:392-399.
16. Hilborn J. Invivo injectable gels for tissue repair. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, [Epub ahead of print]. 10.1002/wnan.91.
17. Gutowska A., Jeong B., Jasionowski M. Injectable gels for tissue engineering. Anat Rec 2001, 263:342-349.
18. Puetzer J.L., Bonassar L.J. High density type I collagen gels for tissue engineering of whole Menisci. Acta Biomater 2013, 9:7787-7795.
19. Wallace D.G., Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 2003, 55:1631-1649.
20. Lang I., Schweizer A., Hiden U., Ghaffari-Tabrizi N., Hagendorfer G., Bilban M., et al. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 2008, 76:1031-1043.
21. Stangel-Wojcikiewicz K., Malgorzata S., Nikolavsky D., Chancellor M.B. Cellular therapy for treatment of stress urinary incontinence. Curr Stem Cell Res Ther 2010, 5:57-62.
22. Das H., George J.C., Joseph M., Das M., Abdulhameed N., Blitz A., et al. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 2009, 4:e7325.
23. Shudo Y., Miyagawa S., Fukushima S., Saito A., Shimizu T., Okano T., et al. Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model. JThorac Cardiovasc Surg 2011, 142:1188-1196.
24. Lindvall O., Kokaia Z., Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 2004, 10(Suppl.):S42-S50.
25. Kang S.K., Kang K.S., Jee M.K., Kim B.S. Vascular endothelial growth factor/kinase insult domain receptor (KDR)/fetal liver kinase 1 (FLK1)-mediated skin-epithelial progenitor cells reprogramming. Tissue Eng Part A 2010, 16:2687-2697.
26. Imoukhuede P.I., Popel A.S. Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. PLoS One 2012, 7:e44791.
27. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006, 291:R880-R884.
28. Wang Y., Haider H.K., Ahmad N., Xu M., Ge R., Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. JMol Cell Cardiol 2006, 40:736-745.
29. Nomi M., Miyake H., Sugita Y., Fujisawa M., Soker S. Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther 2006, 1:333-343.
30. Becker C., Jakse G. Stem cells for regeneration of urological structures. Eur Urol 2007, 51:1217-1228.
31. Mitterberger M., Pinggera G.M., Marksteiner R., Margreiter E., Fussenegger M., Frauscher F., et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol 2008, 53:169-175.
32. Kim M.H., Hong H.N., Hong J.P., Park C.J., Kwon S.W., Kim S.H., et al. The effect of VEGF on the myogenic differentiation of adipose tissue derived stem cells within thermosensitive hydrogel matrices. Biomaterials 2010, 31:1213-1218.
33. Youssif M., Shiina H., Urakami S., Gleason C., Nunes L., Igawa M., et al. Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation. Urology 2005, 66:201-207.
34. O'Sullivan R., Karantanis E., Stevermuer T.L., Allen W., Moore K.H. Definition of mild, moderate and severe incontinence on the 24-hour pad test. BJOG 2004, 111:859-862.
35. Gunasekaran K. Stress urinary incontinence - an overview. JIndian Med Assoc 2011, 109:721-722.
36. Stangel-Wojcikiewicz K., Majka M., Basta A., Stec M., Pabian W., Piwowar M., et al. Adult stem cells therapy for urine incontinence in women. Ginekol Pol 2010, 81:378-381.